Prevalence of acquired and inherited risk factors for Budd-Chiari syndrome (BCS) and portal vein thrombosis (PVT)
Acquired risk factor . | Inherited risk factor . | BCS (%) n = 43 . | PVT (%) n = 92 . |
---|---|---|---|
− | − | 11 (25.6) | 15 (16.3) |
+ | − | 18 (41.8) | 60 (65.2) |
− | + | 8 (18.6) | 4 (4.3) |
+ | + | 6 (13.9) | 13 (14.1) |
Acquired risk factor . | Inherited risk factor . | BCS (%) n = 43 . | PVT (%) n = 92 . |
---|---|---|---|
− | − | 11 (25.6) | 15 (16.3) |
+ | − | 18 (41.8) | 60 (65.2) |
− | + | 8 (18.6) | 4 (4.3) |
+ | + | 6 (13.9) | 13 (14.1) |
BCS: Inherited risk factor: factor V Leiden mutation n = 11, prothrombin gene mutation n = 2, protein C deficiency n = 4. Acquired risk factor: oral contraceptives n = 12, myeloproliferative disease n = 12, lupus anticoagulant n = 2, inflammatory bowel disease n = 2, liver abscess n = 1.
PVT: Inherited risk factor: factor V Leiden mutation n = 7, prothrombin gene mutation n = 3, protein C deficiency n = 6, protein S deficiency n = 2, antithrombin deficiency n = 1. Acquired risk factor: oral contraceptives n = 12, myeloproliferative disease n = 16, cirrhosis n = 16, abdominal surgery n = 28, pancreatitis n = 10, umbilical vein infection n = 6, inflammatory bowel disease n = 4, liver abscess n = 4, abdominal trauma n = 2, paroxysmal nocturnal hemoglobinuria n = 2, pregnancy n = 2, nodular regenerative hyperplasia n = 2, portal sclerosis n = 1, hepatocellular carcinoma n = 1, seminoma n = 1.